ArticleClinical case reports2025
Acute Ischemic Stroke in the Setting of Neurosarcoidosis.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of a 59-year-old male with a history of hypertension, polycythemia, and optic neuritis, who presented with progressive visual loss, bilateral lower extremity weakness, and new-onset urinary and fecal incontinence. MRI findings of leptomeningeal enhancements raised suspicion for neurosarcoidosis, leading to initial treatment with intravenous immunoglobulin (IVIG), but with no significant improvement. Six weeks later, the patient developed an acute ischemic stroke, confirmed by MRI, alongside worsening neurological deficits. Further evaluation revealed mediastinal and hilar lymphadenopathy on chest CT, supporting the diagnosis of neurosarcoidosis. Despite a course of high-dose methylprednisolone and immunosuppressive therapy, including mycophenolate mofetil, the patient showed partial recovery in strength but only minimal improvement in vision. At follow-up, MRI demonstrated stable disease with new leptomeningeal enhancement, prompting the initiation of TNF-alpha inhibitors. This case underscores the rare but important association between neurosarcoidosis and ischemic stroke, highlighting the complexity of diagnosis and management, which includes both stroke prevention and sarcoidosis treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.